GSK Says FDA Rejected Zofran Label Change
By Emily Field · November 10, 2020, 10:06 PM EST
GlaxoSmithKline on Monday told a Massachusetts federal judge overseeing multidistrict litigation over its anti-nausea medicine Zofran that the U.S. Food and Drug Administration has rejected a proposed label change that would...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login